The odyssey of marine pharmaceuticals: a current pipeline perspective. - Test2 - elhamkhani - TriplyDB

The odyssey of marine pharmaceuticals: a current pipeline perspective.

The odyssey of marine pharmaceuticals: a current pipeline perspective.

http://www.wikidata.org/entity/Q34108147

about

Marine Invertebrate Metabolites with Anticancer Activities: Solutions to the "Supply Problem"Exploring the ocean for new drug developments: Marine pharmacology Targeted metagenomics as a tool to tap into marine natural product diversity for the discovery and production of drug candidates Are the Traditional Medical Uses of Muricidae Molluscs Substantiated by Their Pharmacological Properties and Bioactive Compounds?Signal Transducers and Activators of Transcription (STAT) Regulatory Networks in Marine Organisms: From Physiological Observations towards Marine Drug Discovery Peptide neurotoxins that affect voltage-gated calcium channels: a close-up on ω-agatoxins Lessons from the past and charting the future of marine natural products drug discovery and chemical biology Marine invertebrate xenobiotic-activated nuclear receptors: their application as sensor elements in high-throughput bioassays for marine bioactive compounds Approved Antiviral Drugs over the Past 50 Years The Pharmacological Potential of Non-ribosomal Peptides from Marine Sponge and Tunicates Marine-Derived Pharmaceuticals - Challenges and Opportunities Variation in tropical reef symbiont metagenomes defined by secondary metabolism Inhibition of both protease and helicase activities of hepatitis C virus NS3 by an ethyl acetate extract of marine sponge Amphimedon sp Discovery of potent broad spectrum antivirals derived from marine actinobacteria Relationships within Cladobranchia (Gastropoda: Nudibranchia) based on RNA-Seq data: an initial investigation Anti-proliferative effect of methanolic extract of Gracilaria tenuistipitata on oral cancer cells involves apoptosis, DNA damage, and oxidative stress.In vitro and in vivo activities of antibiotic PM181104.Antiproliferative and Proapoptotic Activities of Marine Sponge Hyrtios erectus Extract on Breast Carcinoma Cell Line (MCF-7).Peptides, Peptidomimetics, and Polypeptides from Marine Sources: A Wealth of Natural Sources for Pharmaceutical Applications.Bioactive marine drugs and marine biomaterials for brain diseases Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.Furanoterpene Diversity and Variability in the Marine Sponge Spongia officinalis, from Untargeted LC-MS/MS Metabolomic Profiling to Furanolactam Derivatives.Marine microorganism-invertebrate assemblages: perspectives to solve the "supply problem" in the initial steps of drug discovery Highlights of marine invertebrate-derived biosynthetic products: their biomedical potential and possible production by microbial associants Marine natural products: a new wave of drugs?Antiviral lead compounds from marine sponges.Anticolon cancer activity of largazole, a marine-derived tunable histone deacetylase inhibitor.Didemnaketals f and g, new bioactive spiroketals from a red sea ascidian didemnum species High resolution spatial mapping of brominated pyrrole-2-aminoimidazole alkaloids distributions in the marine sponge Stylissa flabellata via MALDI-mass spectrometry imaging.Antiinflammatory and antinociceptive effects in mice of a sulfated polysaccharide fraction extracted from the marine red algae Gracilaria caudata.Immense essence of excellence: marine microbial bioactive compounds Marine antitumor drugs: status, shortfalls and strategies.The expanding role of marine microbes in pharmaceutical development.A historical overview of natural products in drug discovery.Bioactive natural products from Papua New Guinea marine sponges.Coibamide A, a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts.Three new asperentin derivatives from the algicolous fungus Aspergillus sp. F00785.Bacterial communities of the gorgonian octocoral Pseudopterogorgia elisabethae.Diversity and biological activities of the bacterial community associated with the marine sponge Phorbas tenacior (Porifera, Demospongiae).Culturable rare Actinomycetes: diversity, isolation and marine natural product discovery.

P2860

Q26746924-6C32EA7A-33C3-4205-A8AA-1EE94205BC96 Q26748686-DC1B08B6-5F7D-42EC-AD15-A06240690FCF Q26784489-180AC4C4-A886-422C-8557-4E6908BEBDC5 Q26795884-E0928AF2-232B-4727-842B-5B5BE4B7F157 Q26799332-F48412DB-EA3A-4F26-AC0F-9BB3AE1BB378 Q26826875-164BEA15-7560-48FF-BF52-E3C0996E80D1 Q26863108-5A9AF890-BFEC-4B04-BABE-C296ADC305F2 Q27022545-B4CD5FD4-9B83-46BD-814C-664E623ED52B Q27755387-0F69ACD3-83CD-43A0-BB9F-367C3BBFBC07 Q28074153-EE7CA1A8-C4E8-4EDB-8083-12145B017D62 Q28075572-CD0FAF6A-2BCE-4E2C-9062-1D771D1919E0 Q28477460-B4EF8253-CA60-4B67-AB35-13C525283D07 Q28484965-DF0BB112-82D0-487B-9188-9A4618440EBB Q28536663-EF989E91-2DD9-47EF-8011-D77C09CA8C88 Q28606845-1347AC95-5BA1-48CE-A414-D2362D8BEFD1 Q31088405-39879983-2A68-4D57-AE79-E21B377B1C96 Q31126282-28C6DFDF-ABB2-4FB5-B3A9-E1D744611EE0 Q33609211-2CCA9518-6B7A-488F-B91A-C9B46FF04454 Q33612302-E5DBF475-19AD-47FB-BE4C-97943F1F7327 Q33736687-E7812E5B-D69E-4CA7-9F97-0E797E3D4ED0 Q33834080-9B9B3350-AD7A-4895-A2F5-638A445D262C Q33844969-33530279-25A3-46F0-8DC6-E2535AF9916E Q33963528-1CD33DB9-AB98-4387-A338-12C5A48A6697 Q33991275-9C77DB2B-E027-4C4E-8B2B-C3FD896F0D64 Q34007283-9164A7B3-1DFD-4EA8-9024-95F5A5C2AE44 Q34152399-7A2AA63E-514F-42B7-9D05-3958B05CD298 Q34257533-2551F424-A4DB-47C6-B83B-0610B6948740 Q34260294-9F8ADCD9-63D0-40BF-BBF7-D65EC5B668CF Q34331641-AFC8D51C-9E81-45D6-84FB-45DC5160385E Q34351525-255DF294-D7BE-4E31-BEFE-3A7B7A47D7AE Q34356553-F962C983-FB40-4215-8DB9-9FC780015DCD Q34356560-7A1E1B78-DCC3-430B-A7DA-521A1664D522 Q34362843-00527BE4-9B29-498F-A277-A092A98BFA74 Q34426191-73663AC6-D9E3-4BC0-9DB9-5C4497BC057E Q34451799-79080A4E-0FE7-4F95-AD64-EDA27B1B6360 Q34501525-4F2ADA1F-BA3D-4A5C-8493-8BFE3B5C1577 Q34780550-46387819-8CCD-460E-B4E6-F8D81D142C86 Q34891815-3612C4EF-36AE-4996-BE0B-0474C8C5D8EB Q34986632-CDC79748-405E-44E7-98D5-78995B9FBADD Q34993999-CFDE4632-E91C-4737-8912-1195235287C8

P2860

The odyssey of marine pharmaceuticals: a current pipeline perspective.

http://www.wikidata.org/entity/Q34108147

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

The odyssey of marine pharmaceuticals: a current pipeline perspective.

@ast

The odyssey of marine pharmaceuticals: a current pipeline perspective.

@en

The odyssey of marine pharmaceuticals: a current pipeline perspective.

@nl

type

label

The odyssey of marine pharmaceuticals: a current pipeline perspective.

@ast

The odyssey of marine pharmaceuticals: a current pipeline perspective.

@en

The odyssey of marine pharmaceuticals: a current pipeline perspective.

@nl

prefLabel

The odyssey of marine pharmaceuticals: a current pipeline perspective.

@ast

The odyssey of marine pharmaceuticals: a current pipeline perspective.

@en

The odyssey of marine pharmaceuticals: a current pipeline perspective.

@nl

P1433

Q34108147-E981F057-5BDD-4FC7-9811-C8746308E920

P1476

Q34108147-10436AE5-AA24-42B6-9D2B-431E862965AF

P2093

Q34108147-45E2D3FD-7108-43B2-9D48-CBD164C5A221

Q34108147-45E7537E-83F1-47A0-8DD4-4641F1BEC0B4

Q34108147-54E16F6B-7F59-4374-88EF-E3BFBCE0733C

Q34108147-581B311D-1F8C-4E9B-AC71-54E86BA60D1D

Q34108147-5858B852-AD9D-4ECC-ADF2-943FCB7FBAD2

Q34108147-96DE1C2C-7AB4-4846-B11A-AD0400DA7892

Q34108147-97F29600-5FD5-49C6-9F0E-0D8B388911B6

Q34108147-C3C1BCF1-0345-4732-B9F2-5D0E7B1C661D

Q34108147-E87A4B68-4849-4BAA-8909-B0088F4AFBE5

P304

Q34108147-8EBFA5B8-2338-4F23-9198-E37EBC0506FD

P31

Q34108147-57179CDF-CE88-48D7-9E6B-BBD40590D554

P356

Q34108147-B19BCFFE-79DD-4044-A8C0-7A58BF8966F6

P433

Q34108147-DFD33961-75AB-46E5-808B-5B96FDAA07E4

P478

Q34108147-2AE2BD9C-2F05-492A-9D3E-0FE41BEF88BC

P50

Q34108147-CD098BD7-9F3C-4FAF-9F6D-A422691AD403

P577

Q34108147-6B9F2BE7-2361-43A9-A53B-CE70BA630588

P5875

Q34108147-0714B7E9-C1D7-490F-84DC-6177C25D9109

P698

Q34108147-E5C3C58E-179F-4A25-8A11-F7E2FE50D107

P356

J.TIPS.2010.02.005

P1433

Trends in Pharmacological Sciences

P1476

The odyssey of marine pharmaceuticals: a current pipeline perspective

@en

P2093

Barbara C Potts

http://www.w3.org/2001/XMLSchema#string

Carmen Cuevas

http://www.w3.org/2001/XMLSchema#string

Dale E Shuster

http://www.w3.org/2001/XMLSchema#string

David J Newman

http://www.w3.org/2001/XMLSchema#string

J Michael McIntosh

http://www.w3.org/2001/XMLSchema#string

Keith B Glaser

http://www.w3.org/2001/XMLSchema#string

R Daniel Little

http://www.w3.org/2001/XMLSchema#string

Robert S Jacobs

http://www.w3.org/2001/XMLSchema#string

William Kem

http://www.w3.org/2001/XMLSchema#string

P304

255-265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TIPS.2010.02.005

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Alejandro Mayer

P577

2010-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

222416508

http://www.w3.org/2001/XMLSchema#string

P698

20363514

http://www.w3.org/2001/XMLSchema#string